This is in accordance with the underlying proteinopathy, as GRN and C9ORF72 genetic patients are associated with a TDP-43 deposition, whereas MAPT genetic patients are characterized by a tau protein deposition. This evidence concerns the gene MAPT and proteostasis deficiencies.